Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Dec 10;31(2):94–99. doi: 10.1016/0198-8859(91)90011-W

Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls

A Alpérovitch a,∗, C Berr a, A Cambon-Thomsen b, J Puel c, J-M Dugoujon d, J-B Ruidavets e, M Clanet e
PMCID: PMC7134667  PMID: 2066275

Abstract

Our purpose was to investigate possible interrelations between antibody titers against seven viruses (measles, rubella, herpes simplex, mumps, varicella-zoster, coronavirus, cytomegalovirus), HLA-class II antigens, and immunoglobulin Gm allotypes in multiple sclerosis (MS). We studied 57 MS patients and 59 controls with similar age and sex distributions. In MS patients, we found the classical increased frequency of HLA-DR2, HLA-DQw1 and also an excess of Gm (3; ±23; 5*). Mumps antibody levels were higher in MS patients than in controls; elevation was not significant for measles antibodies. Analysis suggests that an association between HLA-DQwl and antibody titers against various viruses exists in controls but is absent in MS patients. In particular, we found that mumps antibody titers were higher in DQwl-positive than in DQwl-negative controls, while there was no significant difference among MS cases. Accordingly, we found that the overall difference between patients and controls was due to the fact that DQwl-positive patients had higher titers than controls, while DQwl-negative cases had similar titers as controls. These findings suggest that biological and molecular characteristics of DQwl might differ in MS patients.

Abbreviations: Gm heavy chain immunoglobin G, MS multiple sclerosis

References

  • 1.Norrby E. Viral antibodies in multiple sclerosis. In: Melnick J.L., editor. vol 24. Basel; Karger: 1978. (Progress in Medical Virology). [PubMed] [Google Scholar]
  • 2.Sumaya C.V., Myers L.W., Ellison G.W. Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol. 1980;37:94. doi: 10.1001/archneur.1980.00500510052009. [DOI] [PubMed] [Google Scholar]
  • 3.Compston D.A.S., Varkarelis B.N., Paul E., McDonald W.I., Batchelor J.R., Mims C.A. Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain. 1986;109:325. doi: 10.1093/brain/109.2.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.De Vries R.R.P., Vruftenberg H.G., Loggen H.G., Van Rood I.I. In vitro immune responsiveness to vaccinia virus and HLA. N Engl J Med. 1977;297:692. doi: 10.1056/NEJM197709292971303. [DOI] [PubMed] [Google Scholar]
  • 5.Mackay I.R., Whittingham S., Tait B. Genetic control of immune responsiveness in man. Vox Sang. 1977;32:10. doi: 10.1111/j.1423-0410.1977.tb00598.x. [DOI] [PubMed] [Google Scholar]
  • 6.Kato S., Muranaka S., Takakura I., Kimura M., Kimiyoshi T. HLA-DR antigens and the rubella specific immune response in man. Tissue Antigens. 1982;19:140. doi: 10.1111/j.1399-0039.1982.tb01430.x. [DOI] [PubMed] [Google Scholar]
  • 7.Cohen J.H.M., Vischer T.L., Carquin J., Blanchard F., Von Fliedner V.E., Jeannet M. HLA-DR antigens and the antibody response against Epstein-Barr virus. Tissue Antigens. 1984;23:156. doi: 10.1111/j.1399-0039.1984.tb00026.x. [DOI] [PubMed] [Google Scholar]
  • 8.Pandey J.P., Fudenberg H.H. Perspectives on the genetics of the Gm system and its role in immune responses and diseases. Clin Immunol Allergy. 1984;4:641. [Google Scholar]
  • 9.Blanc M., Clanet M., Berr C., Dugoujon J.M., Ruidavets J.B., Ducos J., Rascol A., Alpérovitch A. Immunoglobulin allotypes and susceptibility to multiple sclerosis. J Neurol Sci. 1986;75:1. doi: 10.1016/0022-510x(86)90045-6. [DOI] [PubMed] [Google Scholar]
  • 10.Propert D.N., Bernard C.C.A., Simons M.J. Gm allotypes in multiple sclerosis. J Immunogenet. 1982;9:359. doi: 10.1111/j.1744-313x.1982.tb00994.x. [DOI] [PubMed] [Google Scholar]
  • 11.Berr C., Puel J., Clanet M., Ruidavets J.B., Mas J.L., Alpérovitch A. Risk factors in multiple sclerosis: A population-based case-control study in Hautes-Pyrénées, France. Acta Neurol Scand. 1989;80:46. doi: 10.1111/j.1600-0404.1989.tb03841.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Poser C.M., Paty D.W., Scheimberg L. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann Neurol. 1983;13:277. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  • 13.Vyas G.N., Fudenberg H.H., Pretty H.M., Gold E.R. A new rapid method for genetic typing of human immunoglobulin. J Immunol. 1968;100:274. [PubMed] [Google Scholar]
  • 14.Ceppellini R., Frumento G., Ferrara G.B., Tosi R., Chersi A., Pernis B. Binding labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature. 1989;339:392. doi: 10.1038/339392a0. [DOI] [PubMed] [Google Scholar]
  • 15.Jersild C., Svejgaard A., Fog T., Amitzboll T. HLA antigens and diseases. I. Multiple sclerosis. Tissue Antigens. 1973;3:243. doi: 10.1111/j.1399-0039.1973.tb01002.x. [DOI] [PubMed] [Google Scholar]
  • 16.Arnason B.G.W., Fuller T.C., Lehrich J.R. Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J Neurol Sci. 1974;22:419. doi: 10.1016/0022-510x(74)90078-1. [DOI] [PubMed] [Google Scholar]
  • 17.Alter M., Harshe M., Anderson E. Genetic association of multiple sclerosis and HLA determinants. Neurology. 1976;26:31. doi: 10.1212/wnl.26.1.31. [DOI] [PubMed] [Google Scholar]
  • 18.Fewster M.E., Frances R.A., Botha M.C. Measles antibodies and histocompatibility types in multiple sclerosis. J Neurol Sci. 1979;43:19. doi: 10.1016/0022-510x(79)90070-4. [DOI] [PubMed] [Google Scholar]
  • 19.Elridge R., McFarland H., Sever J., Sadowsky D., Krebs H. Familial multiple sclerosis: Clinical, histocompatibility and viral serological studies. Ann Neurol. 1978;3:72. doi: 10.1002/ana.410030111. [DOI] [PubMed] [Google Scholar]
  • 20.Poskanser D.C., Sever J.L., Terasaki P.I., Prenney L.B., Sheridam I.L., Park M.S. Multiple sclerosis in the Orkney and Shetland Islands: The effect on viral antibody titers of histocompatibility determinants. J Epidemiol Community Health. 1980;34:265. doi: 10.1136/jech.34.4.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Spielman R.S., Baur M.P., Clerget-Darpoux F. Genetic analysis of IDDM; Summary of GAW 5 IDDM results. Genet Epidemiol. 1989;6:43. doi: 10.1002/gepi.1370060111. [DOI] [PubMed] [Google Scholar]
  • 22.Doffeol M., Tongio M.M., Gut I.P., Ventre G., Charrault A., Vetter D. Relationships between 34 HLA-A, HLA-B and HLA-DR antigens and three serological markers of viral infections in alcoholic cirrhosis. Hepatology. 1986;6:457. doi: 10.1002/hep.1840060323. [DOI] [PubMed] [Google Scholar]
  • 23.Benssusan A. Les lymphocytes T humains: Un modèle unique de reconnaissance. Medecine/Sciences. 1988;12:21. [Google Scholar]
  • 24.Vartdal F., Vandvik B., Norrby E. Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol. 1980;8:248. doi: 10.1002/ana.410080305. [DOI] [PubMed] [Google Scholar]
  • 25.Grenner N.E., Johnson K.P., Flein G., Likosky W.H. Comprehensive viral immunology of multiple sclerosis. II. Analysis of serum and CSF antibodies by standard serologic methods. Arch Neurol. 1980;37:610. doi: 10.1001/archneur.1980.00500590034003. [DOI] [PubMed] [Google Scholar]

Articles from Human Immunology are provided here courtesy of Elsevier

RESOURCES